"In February 2020, Apabetalone became the first therapy of its kind to have been granted US FDA Breakthrough Therapy Designation, for a major cardiovascular indication, to help facilitate a time-efficient drug development program including planned clinical trials and plans for expediting the manufacturing development strategy."
top of page
Recent PostsSee All
The proceeds will be used for research and development expenses primarily to advance its lead kt-3000 program toward human clinical trials
Health Gauge Inc, is developing certain AI-powered powered products and services exclusively for World Weight Loss.
“The Rakovina Therapeutics team is committed to developing new treatments that will improve outcomes for cancer patients,”
bottom of page